Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,356 GBX | +0.23% |
|
-0.93% | +16.57% |
06-27 | US FDA declines to approve Merck-Daiichi's 'guided missile' cancer drug | RE |
06-26 | European Equities Close Lower in Wednesday Trading | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.57% | 242B | |
+56.09% | 819B | |
-6.84% | 351B | |
+17.75% | 329B | |
+9.46% | 298B | |
+2.04% | 225B | |
+13.31% | 217B | |
+7.95% | 168B | |
-2.71% | 158B | |
+0.20% | 120B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Says Imfinzi With Chemotherapy Improves Survival in Phase 3 Bladder Cancer Trial